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Conclusions and Implications
Results
 Increases in the use of psychotropic medications have occurred despite 
diagnostic challenges, the relative lack of safety and efficacy of these drugs, 
and concerns about their effects on developing brains of young children.
 Clinicians need to be aware of the current treatment recommendations and the 
availability of non-pharmacological interventions and carefully weigh the risks 
and benefits of psychotropic medication in young children. 
 Efforts to improve access to non-pharmacological mental health services, 
psychoeducation for patients and families, and decision support for providers in 
the general medical setting are warranted.  
 Social workers need to be aware of treatment options and availability of 
services to connect preschool aged children and families to the appropriate 
resources.
 Measures
− Psychotropic Medication Use
• Definition: ≥ 1 psychotropic 
medication at any time during the 
year
• 6 major drug classes
• Antidepressants
• Antipsychotics
• Mood stabilizers
• Stimulants 
• Alpha-agonists
• Anxiolytics
− Exclusions
• Anticonvulsants meds with epilepsy
• Alpha-agonists with hypertension
 Trends in Psychotropic Use
−Rates of medication use remained stable between 2002 and 2008
• Stimulants, alpha-agonists, anxiolytics, antipsychotics most 
common
• Most drugs prescribed by primary care doctors 
− Increased use of:
• Antipsychotics,
• Stimulants,
• Alpha-agonists
−Decreased use of :
• Antidepressants 
• Mood stabilizers
−Rates of antipsychotic use more than doubled 
• Most prescribed risperidone
• Most were diagnosed with behavior disorders
− Key findings from the multivariate analysis:
• ↑ medication use for older, white, male, disabled, and in foster 
care  
• ↑ medication use  for those diagnosed with ADHD, bipolar, 
disruptive behavior, and autism
 Trends in Mental Health Service Use
−Most children treated with medications did not receive a mental 
health assessment, a psychiatry visit, or psychotherapy
Background
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Any psychotropic Alpha-agonist Antidepressant
Antipsychotic Mood stabilizer Stimulants
Patterns of psychotropic Medication use Among Medicaid-
Enrolled Preschoolers 
Aged 2-5, Ohio, 2002-2008 
Note. Linear trend tests are significant for all drug classes at the p=0.001 level
2002 2008 Linear trend 
test, pN % N %
Any mental health service 1,448 62.09 2,610 73.40 < .001
Outpatient services 1,447 62.05 2,609 73.37 < .001
Specialtya 910 39.02 1,458 41.00 .013
MH assessment 587 25.17 1,009 28.37 < .001
Psychiatrist visit 597 25.60 843 23.71 .752
Psychotherapy 621 26.63 1,056 29.70 .024
Non-specialtyb 1,131 48.50 2,255 63.41 < .001
Inpatient psychiatric services 44 1.89 63 1.77 .614
Patterns of Mental Health Service Use for Preschoolers 
Treated with Psychotropic Medication, 
Ohio Medicaid, 2002-2008
Note. Linear trend tests based on all 7years of data.
aSpecialty services include outpatient services in the community mental health system and services provided by a mental health specialist such as 
psychiatrist, social worker, or psychologist. bNon-specialty services include evaluation and management visits by a primary care physician, 
pediatrician or nurse practitioner.
Strengths
 Population data
 Examination of prescribing trends  
 Examination of context of medication 
prescribing:
− Type of prescribing provider
• Specialty vs.  Non-specialty     
− Mental health service use
Limitations
 Generalizability
−Other state programs
−Non-Medicaid populations
 Claims data lack information on:
−Physician characteristics
−Patient attitudes about meds
−Family factors
−Level of functional impairment
 Pharmacy claims do not measure 
actual consumption of meds
2002 2008 Linear trend 
test, pN % N %
Total on medication 2,332 3,556
Demographics
Age group, y
2-3 554 23.76 775 21.79
.024
4-5 1,778 76.24 2,781 78.21
Male 1,572 67.41 2,432 68.39 .032
Race
White 1,843 79.03 2,798 78.68 .114Non-whitea 489 20.97 758 21.32
Eligibility category
Poverty 1,925 82.55 3,057 85.97 .143
Disabled 337 14.45 426 11.98 .737
Foster care 70 3.00 73 2.05 .010
Clinical
Primary mental health diagnosis
None 592 25.39 749 21.06 < .001
Depression 11 0.47 5 0.14 .017
Bipolar 17 0.73 56 1.57 < .001
Schizophrenia or psychosisb 1 0.04 2 0.06 --
Autism 29 1.24 82 2.31 < .001
Anxiety 36 1.54 69 1.94 .029
Adjustment 132 5.66 162 4.56 .538
ADHD 564 24.19 1,167 32.82 < .001
Disruptive behavior 230 9.86 445 12.51 < .001
Communication and learning 76 3.26 322 9.06 < .001
Mental retardation 481 20.63 110 3.09 < .001
Other disorderc 163 6.99 387 10.88 < .001
Number of diagnoses
0 592 25.39 749 21.06 < .001
1 1,094 46.91 1,873 52.67 < .001
≥ 2 646 27.70 934 26.27 .001
Demographic and Clinical Characteristics of 
Preschoolers Treated with Psychotropic Medication, 
Ohio Medicaid, 2002-2008
Note. Linear trend tests based on all 7 years of data. 
aNon-white includes African American (94%); the remainder were Hispanic, Asian, and Pacific Islander. bNo results due to small cell sizes. cIncludes all 
diagnoses with ICD-9-CM codes 290-319 not listed above. 
Estimated Odds Ratios and 99% Confidence Intervals of 
Psychotropic Medication for Selected Demographic and 
Clinical Characteristics 
behavior
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Disruptive
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Odds ratio
Note. Results are based on GEE from logistic regression model predicting psychotropic medication use. The model included the following variables: 
age, race, ethnicity, gender, area of residence (rural/urban), Medicaid eligibility category, primary psychiatric diagnosis, number of psychiatric 
disorders, any medical comorbidities, any MH assessment, psychiatrists visits, any psychotherapy, any partial hospitalizations, any inpatient.  
Reference categories: age: 2-3 years old; Medicaid eligibility category: poverty; ≥ 2 psychiatric diagnoses: 0-1 diagnoses.
 Design 
− Serial, cross-sectional study
 Data Source
− Ohio Medicaid claims files 
• Prescription drug, inpatient, outpatient, 
eligibility/enrollment
Study Population 
−Inclusion Criteria:
•Children aged 2 to 5 years
•Full-year Medicaid eligibility
•Time period: July 1, 2001-June 30, 2008
−Entire Population:
•N = 559,275 
−Analytic Sample:  
•Children prescribed ≥ 1 psychotropic 
med during the study period (n = 23,019)
 Predictor Variables
− Demographic Factors
• Age, race/ethnicity, sex, area of   
residence, Medicaid eligibility
− Clinical Factors
• Primary psychiatric diagnosis
• ICD-9-CM codes: 290-319
• Number of psychiatric disorders
• Comorbid medical conditions
• 12 chronic pediatric conditions
− Mental Health Service Use 
• Outpatient services
• Inpatient psychiatric 
 Statistical Methods
− Generalized estimated equation (GEE) 
logistic regression model of psychotropic 
medication use
Objective: To examine trends and predictors of psychotropic medication use among 
preschoolers in Ohio Medicaid across a 7-year time span.
Methods: A longitudinal retrospective analysis of Medicaid claims data was conducted to 
examine trends in psychotropic medication use among preschool children over the 7 
year period from 2002 to 2008. The study population included all children (aged 2 to 5 
years) who were continuously enrolled in Ohio’s Medicaid program for at least a 12 
month period from July 1, 2001 through June 30, 2008 ((N = 559,275).  Children were 
identified as users of psychotropic medications if they had at least one prescription claim 
during the study period (n = 23,019).
Results: The overall rate of psychotropic medication use per 1,000 children increased 
only slightly from 17 to 19 between 2002 and 2008.  Significant increases in the use of 
stimulants, alpha-agonist medications, and especially antipsychotics, which more than 
doubled from 2 per 1,000 in 2002 to 5 per 1,000 in 2008, were balanced by significant 
decreases in the use of antidepressants and mood stabilizers.  Of those treated with 
psychotropic medications, a little over a quarter (28.4%) had a mental health 
assessment, 23.7% had a visit with a psychiatrist, and 29.7% had a psychotherapy visit.  
Children who were older, white, male, disabled, and in foster care were more likely to 
receive psychotropic medications.  The diagnoses most associated with psychotropic 
medication use were ADHD, bipolar disorder, and disruptive behavior disorders.
Conclusion: This data suggest growth in the proportion of preschoolers being treated 
with antipsychotics, stimulants and alpha agonists, primarily for behavioral disturbances 
and aggressive symptoms.  Most preschool children prescribed psychotropic medication 
do not receive the psychosocial services recommended by current treatment guidelines. 
• To examine trends in psychotropic medication use and mental health service 
use patterns for Medicaid-enrolled preschoolers. 
• To identify demographic, diagnostic, and service use factors associated with 
psychotropic medication use.
•Increased use of psychotropic drugs in young children 
−1.7-3.1 fold increase in stimulants, 1991-1995
−50% of children < 6 yrs. with autism prescribed medications, 2001
−Rate of antipsychotics use more than doubled from 1999 to 2007
•Indications for medication 
− After a trial of psychosocial treatment
−Moderate to severe symptoms and functional impairment
−High risk of injury to self or others
•Concerns and Issues
−Lack of data on effectiveness, safety, or dosing of  drugs 
−Effects on developing brain unknown
−Little knowledge of dosing, tolerability, or drug interactions
−Validity and reliability of many diagnoses not confirmed
• Gaps in Research
− Recent trend in prescribing to preschoolers
− The context in which prescribing occurs
− Factors that affect prescribing decisions
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